Does OCRELIZUMAB Cause Middle insomnia? 75 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 75 reports of Middle insomnia have been filed in association with OCRELIZUMAB (OCREVUS). This represents 0.1% of all adverse event reports for OCRELIZUMAB.
75
Reports of Middle insomnia with OCRELIZUMAB
0.1%
of all OCRELIZUMAB reports
1
Deaths
26
Hospitalizations
How Dangerous Is Middle insomnia From OCRELIZUMAB?
Of the 75 reports, 1 (1.3%) resulted in death, 26 (34.7%) required hospitalization.
Is Middle insomnia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OCRELIZUMAB. However, 75 reports have been filed with the FAERS database.
What Other Side Effects Does OCRELIZUMAB Cause?
Covid-19 (11,454)
Fatigue (5,704)
Urinary tract infection (3,618)
Headache (3,036)
Multiple sclerosis (2,609)
Asthenia (2,509)
Nasopharyngitis (2,479)
Gait disturbance (2,384)
Pneumonia (2,333)
Pain (2,327)
What Other Drugs Cause Middle insomnia?
OMALIZUMAB (1,115)
SODIUM OXYBATE (924)
DUPILUMAB (633)
ALBUTEROL (578)
MONTELUKAST (417)
TASIMELTEON (412)
TIOTROPIUM (373)
BUDESONIDE\FORMOTEROL (371)
PREDNISONE (370)
CARBIDOPA\LEVODOPA (328)
Which OCRELIZUMAB Alternatives Have Lower Middle insomnia Risk?
OCRELIZUMAB vs OCRIPLASMIN
OCRELIZUMAB vs OCTINOXATE\OCTISALATE\ZINC
OCRELIZUMAB vs OCTINOXATE\OCTOCRYLENE
OCRELIZUMAB vs OCTREOTIDE
OCRELIZUMAB vs OCTREOTIDE\OCTREOTIDE